Evidence
Turk Psikiyatri Derg. 2024 Fall;35(3):245-247. doi: 10.5080/u26711.
ABSTRACT
Naltrexone is an μ opioid receptor antagonist that is used in alcohol and opiate use disorder. Naltrexone does not constitute tolerance and dependence, and cessation of the drug does not cause withdrawal symptoms. Sustained release form of naltrexone has been developed due to patient compliance issues. There is currently only one sustainedrelease form available in Turkey, which is inserted subcutaneously. In this case report, we present, a probable serious side effect of sustained release naltrexone implant. A 36 years old male with alcohol use disorder, developed a sudden clouding of consciousness one hour after the naltrexone implant application followed by anterograde amnesia in the next 8-10 hours. We were not able to detect any medical or neurological reasons for the altered mental status but after the removal of the naltrexone implant, the symptoms improved. To the best of our knowledge, this is the first case to report clouding of consciousness and anterograde amnesia after naltrexone implantation. Keywords: Naltrexone Implant, Side Effect, Alcohol Use Disorder, Lethargy, Consciousness.
PMID:39224997 | DOI:10.5080/u26711
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Loss of Consciousness After Naltrexone Implantation: A Case Report
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Loss of Consciousness After Naltrexone Implantation: A Case Report
- A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence
- Neuroprotective effects of naltrexone in a mouse model of post-traumatic seizures
- Catatonia Due to Lithium Neurotoxicity: A Case Report
- Characterizing reward and relief/habit drinking profiles in a study of naltrexone, varenicline, and placebo
- Klingsor Syndrome: Genital Self-Mutilation in a Psychotic Patient
- Impact of hospital-administered extended-release naltrexone on readmission rates for patients with alcohol use disorder
- Impact of hospital-administered extended-release naltrexone on readmission rates for patients with alcohol use disorder
- A 68-Year-Old Man with Depression and Acute Renal Failure Due to Rhabdomyolysis Associated with Alcohol Intoxication While Taking Low-Dose Escitalopram: A Case Report
- A 68-Year-Old Man with Depression and Acute Renal Failure Due to Rhabdomyolysis Associated with Alcohol Intoxication While Taking Low-Dose Escitalopram: A Case Report
- Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial
- Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases
- Comparing the psychometric properties of reward and relief drinking measures
- Reliability and Validity of Turkish version of DSM-5 Substance Use Scale
- Reliability and Validity of Turkish version of DSM-5 Substance Use Scale
- Alcohol Endotheliitis: A Report of a Rare Case
- Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
- The Pharmacological Management of Ketamine Use Disorder: A Systematic Review
- Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts
- Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial
- Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial
- Waxing and waning consciousness in a patient with a midbrain cavernous malformation: illustrative case
- Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
- A case of severe and prolonged γ-hydroxybutyrate (GHB) withdrawal syndrome successfully managed with a slow benzodiazepine and baclofen taper
- Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments
- Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology
- Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers
- Management Challenges and Potential Malabsorption of Valproic Acid in a Patient with Bipolar Disorder and Gastrointestinal History
- Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal
- Lithium Induced Amenorrhea: A First Case Report
- Frequency of Post Traumatic Stress Disorder and Associated Factors Among Survivors of Van Avalanche: 6-Month Follow-up Study
- Centrally administered growth hormone secretagogue receptor antagonist DLys decreases alcohol intake and preference in male mice
- A Case Report and Review of the Literature of ICU Delirium
- Awareness of the potential consequences of alcohol consumption in the context of chronic pain and prescription opioid use
- Oculogyric Crisis Following Dosage Increase of Aripiprazole: A Case Report
- The Effects of Art Therapy and Psychosocial Skills Training on Symptoms and Social Functioning in Patients with Schizophrenia and Their Relatives
- Improvement in inpatient discharge planning for patients with alcohol use disorder with the implementation of a team-based multidisciplinary workflow
- Acute Osmotic Central Pontine Demyelination in an Alcoholic Patient With Normal Sodium Levels and a Vitamin B6 Deficiency
- Treatment of a resistant case of schizoaffective disorder with lumateperone: A case report
- Jeffrey Marshall: Prevention of Future Deaths Report
- Use of light activated intramedullary device for revision of a proximal humerus fracture: a case study
- A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists
- Cholestasis, delirium and pulmonary nocardiosis in a man with systemic lupus erythematosus of late onset
- Withdrawal Dyskinesia Associated With Aripiprazole in a Child: A Case Report
- Factors Associated with Relapses in Alcohol and Substance Use Disorder
- Stefan Walker: Prevention of future deaths report
- Des-acyl ghrelin reduces alcohol intake and alcohol-induced reward in rodents
- The Role of Cannabis in the Development of Psychosis
- Compulsive Biting and Chewing with Mixed Amphetamine Salts: A Case Report
- Margaret Pilgrim: Prevention of future deaths report
- Alan Fallows: Prevention of Future Deaths Report
- Evaluation of Catatonia with Different Assessment Scales in Psychiatry and Neurology
- A case of multiorgan failure due to carbamazepine intoxication successfully treated with multimodal blood purification therapy
- Posttraumatic Stress and Opioid Use and Pain among Individuals with Probable Posttraumatic Stress Disorder and Self-Reported Chronic Pain: The Role of Health Literacy
- Stroke Risk After Emergency Department Treat-and-Release Visit for a Fall
- Barriers To Accessing Mental Health Services Among Syrian Refugees: A Mixed-Method Study
- The Effects of Selective Serotonin Reuptake Inhibitors on Impulsivity in Young Adults with Major Depression in the Early Phase of Treatment
- A synergistic workspace for human consciousness revealed by Integrated Information Decomposition
- Douglas Armstrong: Prevention of Future Deaths Report
- Alcohol Addiction in War Veterans Treated in a In-patient Psychiatric Facility: Incidence, Comorbidity with PTSD Symptoms, Association with Combat Stressors
- Intracranial dissemination of Klebsiella pneumoniae originating from pulmonary infection: a case report
- Christopher MacGillivray: Prevention of future deaths report
- Christopher MacGillivray: Prevention of future deaths report
- Use of sodium oxybate for the treatment of alcohol withdrawal syndrome in patients with acute alcohol-associated hepatitis: A 4-patient case report
Evidence Blueprint
Loss of Consciousness After Naltrexone Implantation: A Case Report
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Loss of Consciousness After Naltrexone Implantation: A Case Report
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Loss of Consciousness After Naltrexone Implantation: A Case Report
- Case Series of Individuals Treated with Naltrexone during Pregnancy for Opioid and/or Alcohol Use Disorder
- The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception
- National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders
- A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence
- Patterns of publicly funded naltrexone use among patients diagnosed with alcohol use disorder in Ontario
- Patterns of publicly funded naltrexone use among patients diagnosed with alcohol use disorder in Ontario
- Exploring the Function of (+)-Naltrexone Precursors: Their Activity as TLR4 Antagonists and Potential in Treating Morphine Addiction
- Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial
- A comparative study of the efficacy of venlafaxine and naltrexone for relapse prevention in patients with opioid use disorder attributed to tramadol
- Neuroprotective effects of naltrexone in a mouse model of post-traumatic seizures
- Catatonia Due to Lithium Neurotoxicity: A Case Report
- COVID-19-induced acute loss of consciousness in Marchiafava-Bignami disease: a case report
- Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review
- Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial
- Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans
- Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems
- Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity
- Transient Fever Response After ECT in a Patient with Catatonic Schizophrenia: A Case Report
- Characterizing reward and relief/habit drinking profiles in a study of naltrexone, varenicline, and placebo
- Klingsor Syndrome: Genital Self-Mutilation in a Psychotic Patient
- Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form
- Suicidal and Homicidal Thoughts as Psychotic Symptoms in an Adolescent: A Case Report
- Alcohol Dependence Syndrome With Bipolar Affective Disorder and Hypomanic Current Episode: A Case Report
- The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report
- Continuous alcohol withdrawal delirium and physical illness-associated delirium in a man brought to the emergency department after a disaster: A case report
- Impact of hospital-administered extended-release naltrexone on readmission rates for patients with alcohol use disorder
- Impact of hospital-administered extended-release naltrexone on readmission rates for patients with alcohol use disorder
- Patient Perspectives on Pharmacotherapy of Alcohol Dependence
- A 68-Year-Old Man with Depression and Acute Renal Failure Due to Rhabdomyolysis Associated with Alcohol Intoxication While Taking Low-Dose Escitalopram: A Case Report
- A 68-Year-Old Man with Depression and Acute Renal Failure Due to Rhabdomyolysis Associated with Alcohol Intoxication While Taking Low-Dose Escitalopram: A Case Report
- Cold nociception as a measure of hyperalgesia during spontaneous heroin withdrawal in mice
- A pilot randomized controlled trial of medication adherence therapy: Psychosocial leverage using a significant other (MAT-PLUS) for individuals on extended-release naltrexone
- Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial
- Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department
- Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases
- ARTIFICIAL INTELLIGENCE INNOVATIONS IN PSYCHIATRY: GLOBAL PERSPECTIVE FROM EARLY CAREER PSYCHIATRISTS
- Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder
- Comparing the psychometric properties of reward and relief drinking measures
- Reliability and Validity of Turkish version of DSM-5 Substance Use Scale
- Reliability and Validity of Turkish version of DSM-5 Substance Use Scale
- Zolpidem Stimulant Effect and Dependence: A Case Report on Intranasal Use
- Alcohol Endotheliitis: A Report of a Rare Case
- Zolpidem Stimulant Effect and Dependence: A Case Report on Intranasal Use
- Zolpidem Stimulant Effect and Dependence: A Case Report on Intranasal Use
- Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
- The Pharmacological Management of Ketamine Use Disorder: A Systematic Review
- Methadone Withdrawal-Induced Psychosis: A Case Report
- Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden
- Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts
- Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial
- Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial
- Hemodynamics and arrhythmia disorder caused by lithium poisoning: A case report
- Severe tianeptine withdrawal symptoms managed with medications for opioid use disorder: a case report
- Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
- Idiopathic hypersomnia with a video recording of a spontaneous sleep attack: A case report
- Microglial knockdown does not affect acute withdrawal but delays analgesic tolerance from oxycodone in male and female C57BL/6J mice
- Establishing a research agenda for the study and assessment of opioid withdrawal
- Waxing and waning consciousness in a patient with a midbrain cavernous malformation: illustrative case
- Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder
- Preparation, characterization, and in vitro/vivo evaluation of a multifunctional electrode coating for cochlear implants
- Methadone Withdrawal-Related Psychosis in a Patient With Hormone-Dependent Breast Cancer: A Case Report
- Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
- A Clinical Suspicion of Quetiapine-Induced Psychosis: A Case Report and Literature Review